Sector
PharmaceuticalsOpen
₹54.7Prev. Close
₹57.51Turnover(Lac.)
₹1.63Day's High
₹58.39Day's Low
₹54.752 Week's High
₹73.252 Week's Low
₹37.4Book Value
₹19.67Face Value
₹10Mkt Cap (₹ Cr.)
45.12P/E
29.8EPS
1.93Divi. Yield
022 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
12 Aug 2023
12:00 AM
BookCloser
14 Aug 2023
12:00 AM
AGM
Announcement Date: 14 Aug, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 7.87 | 7.87 | 7.87 | 7.87 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6.08 | 4.72 | 3.7 | 2.93 |
Net Worth | 13.95 | 12.59 | 11.57 | 10.8 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 26.58 | 27.64 | 18.93 | 29.96 |
yoy growth (%) | -3.85 | 45.99 | -36.81 | -2.06 |
Raw materials | -17.35 | -17.59 | -15.54 | -18.64 |
As % of sales | 65.28 | 63.63 | 82.11 | 62.22 |
Employee costs | -3.76 | -2.36 | -2.14 | -2.29 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.93 | 0.8 | 0.44 | 0.42 |
Depreciation | -0.81 | -0.76 | -0.52 | -0.51 |
Tax paid | -0.21 | -0.42 | 0.09 | -0.23 |
Working capital | 0.77 | -2.84 | 3.28 | 4.31 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.85 | 45.99 | -36.81 | -2.06 |
Op profit growth | -61.52 | -167.92 | -217.49 | -358.67 |
EBIT growth | -6.08 | 41.31 | -23.07 | 12.72 |
Net profit growth | 92.51 | -31.03 | 187.01 | 9.61 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
T G Raghavendra
Whole-time Director
V J Sarma
Non-Exec. & Independent Dir.
O Mohan Rao
Non-Exec. & Independent Dir.
A Satyanarayana Murthy
Non-Exec. & Independent Dir.
Karunasree
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Roopa Industries Ltd
Summary
Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The Company was incorporated in 1985 and operates into manufacturing and marketing of bulk drugs and intermediaries. The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998. Over the years, it has been a principal supplier to many companies in various countries.The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations. It offers triphenyl phosphine for use as wittig reagent in the manufacture of pharmaceuticals and cosmetics; as catalyst in hydroformylation, isomerisation, and polymerisation of olefins; as catalysing and curing agent in a range of polymerization reactions, epoxy resins, and photopolymers; and as reducing and deoxygenating agent in quinones, epoxides, amine oxides, and sulfoxides. The Company produces Active Pharmaceutical Ingredients such as Fluconazole, Sildenafil Citrate, Losartan Potassium and Triphenyl Phosphine (which goes into the production of Cephalosporins, Statins etc.,) and Nutraceuticals such as Glucosamine salts. Triphenyl Phosphine is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins etc,. There are more usages of Triphenyl Phosphin
Read More
What is the Roopa Industries Ltd share price today?
The Roopa Industries Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹57.37 today.
What is the Market Cap of Roopa Industries Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Roopa Industries Ltd is ₹45.12 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Roopa Industries Ltd?
The PE and PB ratios of Roopa Industries Ltd is 29.8 and 2.92 as of 22 Jul ‘24
What is the 52 Week High and Low of Roopa Industries Ltd?
The 52-week high/low is the highest and lowest price at which a Roopa Industries Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Roopa Industries Ltd is ₹37.4 and ₹73.2 as of 22 Jul ‘24
What is the CAGR of Roopa Industries Ltd?
Roopa Industries Ltd's CAGR for 5 Years at 45.20%, 3 Years at 56.51%, 1 Year at 33.59%, 6 Month at 2.57%, 3 Month at -1.24% and 1 Month at -1.69%.
What is the shareholding pattern of Roopa Industries Ltd?
The shareholding pattern of Roopa Industries Ltd is as follows:
Promoters - 48.03 %
Institutions - 0.25 %
Public - 51.72 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
